Join Dr. Rafal Krol for a webinar on creating HLA-genome-edited iPS cell lines to reduce the risk of immune rejection. One of the manufacturing challenges, however, is single-cell cloning. Dr. Krol will discuss his progress developing a single-cell cloning process suitable for manufacturing clinical-grade iPS cells with adherence to cGMP regulations, concentrating on automated single-cell dispensing and culture protocol optimization.
